MedTrace Logo

The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients

NCT05902676 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-06-15

No results posted yet for this study

Summary

The anticholinergic burden was calculated based on the medications that the patients had used for more than 10 days. Short-term medications used by patients were not evaluated. Among all the medications used by the patients, those with anticholinergic effects were scored according to the scale, and the total anticholinergic burden was calculated by adding them up. Those who had no anticholinergic score were considered to have no anticholinergic burden.

The study cohort will be stratified into two cohorts, distinguished by the presence or absence of anticholinergic burden. To evaluate the impact of anticholinergic burden on daily living activities and instrumental ADL, the groups will be compared with respect to hand grip strength and walking speed.In this study, the anticholinergic burden will be calculated based on medications used by the patients for more than 10 days, excluding short-term medications. Each medication with anticholinergic effects will be assigned a score according to a scale, and the total anticholinergic burden will be determined by summing up the scores. Patients without any anticholinergic score will be classified as having no anticholinergic burden.

The study cohort will be divided into two groups based on the presence or absence of anticholinergic burden. To assess the impact of anticholinergic burden on daily living activities (ADLs) and instrumental ADLs, the groups will be compared in terms of hand grip strength and walking speed.

Conditions

  • Anticholinergic Syndrome
  • Anticholinergic Adverse Reaction
  • Antispasmodic Adverse Reaction
  • Antiarrhythmic Drug Adverse Reaction
  • Antiparkinsonism Drugs Causing Adverse Effects in Therapeutic Use
  • Psychotropic Agents Causing Adverse Effects in Therapeutic Use

Sponsors & Collaborators

  • Izmir Ataturk Training and Research Hospital

    lead OTHER

Principal Investigators

  • Hasan Oztin, MD · Izmir Katip Celebi University, Ataturk Education And Research Hospital,

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2023-07-30
Completion
2023-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05902676 on ClinicalTrials.gov